These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7533788)

  • 21. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgM autoantibodies against two cellular antigens always appear in acute Epstein-Barr virus infection.
    Ritter K; Brestrich H; Thomssen R
    Scand J Infect Dis; 1990; 22(2):135-43. PubMed ID: 2162556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
    Rhodes G; Carson DA; Valbracht J; Houghten R; Vaughan JH
    J Immunol; 1985 Jan; 134(1):211-6. PubMed ID: 2981091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.
    Lindsey JW; deGannes SL; Pate KA; Zhao X
    Mol Immunol; 2016 Jan; 69():7-12. PubMed ID: 26637929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1.
    Venables PJ; Pawlowski T; Mumford PA; Brown C; Crawford DH; Maini RN
    Ann Rheum Dis; 1988 Apr; 47(4):270-9. PubMed ID: 2452607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
    Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral infection can induce the production of autoantibodies.
    Barzilai O; Ram M; Shoenfeld Y
    Curr Opin Rheumatol; 2007 Nov; 19(6):636-43. PubMed ID: 17917546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.
    Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Sample C; Parker B
    Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manganese superoxide dismutase as a target of autoantibodies in acute Epstein-Barr virus infection.
    Ritter K; Kühl RJ; Semrau F; Eiffert H; Kratzin HD; Thomssen R
    J Exp Med; 1994 Nov; 180(5):1995-8. PubMed ID: 7964476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
    Mameli G; Cossu D; Cocco E; Masala S; Frau J; Marrosu MG; Sechi LA
    J Neuroimmunol; 2014 May; 270(1-2):51-5. PubMed ID: 24642384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a human-specific epitope in a conserved region of the La/SS-B autoantigen.
    Weng YM; McNeilage J; Topfer F; McCluskey J; Gordon T
    J Clin Invest; 1993 Aug; 92(2):1104-8. PubMed ID: 7688758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells.
    Khanna R; Jacob CA; Burrows SR; Kurilla MG; Kieff E; Misko IS; Sculley TB; Moss DJ
    Immunology; 1991 Nov; 74(3):504-10. PubMed ID: 1722774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
    Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
    Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Petersen J; Rhodes G; Roudier J; Vaughan JH
    Arthritis Rheum; 1990 Jul; 33(7):993-1000. PubMed ID: 2164400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein.
    Rowe DT; Clarke JR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1217-29. PubMed ID: 2471806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen.
    Fox R; Sportsman R; Rhodes G; Luka J; Pearson G; Vaughan J
    J Clin Invest; 1986 May; 77(5):1539-47. PubMed ID: 2422209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus.
    Poole BD; Scofield RH; Harley JB; James JA
    Autoimmunity; 2006 Feb; 39(1):63-70. PubMed ID: 16455583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human monoclonal antibodies to viral peptides.
    Sidorova E; Borisova T; Lyakisheva L; Rosen A
    Hum Antibodies; 1997; 8(2):65-9. PubMed ID: 9289390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.